Trial Profile
A Randomized, Open-label, Active-controlled, Single/Multiple-dose Phase 1 Clinical Trial to Evaluate Pharmacokinetics/Pharmacodynamics and Safety/Tolerability of Tegoprazan After Oral Administration in Healthy Male Subjects
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Tegoprazan (Primary) ; Esomeprazole
- Indications Erosive oesophagitis; Gastric ulcer; Gastro-oesophageal reflux; Helicobacter infections
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors HK inno.N
- 23 May 2018 New trial record